{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T18:09:50Z","timestamp":1789582190783,"version":"build-2803163510"},"reference-count":69,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003495","name":"Hessisches Ministerium f\u00fcr Wissenschaft und Kunst","doi-asserted-by":"publisher","award":["LOEWE\/1\/10\/519\/03\/03.001(0016)\/53"],"award-info":[{"award-number":["LOEWE\/1\/10\/519\/03\/03.001(0016)\/53"]}],"id":[{"id":"10.13039\/501100003495","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003495","name":"Hessisches Ministerium f\u00fcr Wissenschaft und Kunst","doi-asserted-by":"publisher","award":["LOEWE\/5\/A005\/519\/06\/00.006(0001)\/E33"],"award-info":[{"award-number":["LOEWE\/5\/A005\/519\/06\/00.006(0001)\/E33"]}],"id":[{"id":"10.13039\/501100003495","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jlr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jlr.2025.100910","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T03:56:36Z","timestamp":1758686196000},"page":"100910","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Carrier cross-reactivities of the bile acid reabsorption inhibitors elobixibat, linerixibat, maralixibat, and odevixibat"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-7772-3206","authenticated-orcid":false,"given":"Veronica","family":"Billo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Neelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5651-1241","authenticated-orcid":false,"given":"Marie","family":"Wannowius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Neubauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e4rbel","family":"F\u00fchler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohannes","family":"Hagos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2663-1858","authenticated-orcid":false,"given":"Joachim","family":"Geyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jlr.2025.100910_bib1","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1194\/jlr.R054114","article-title":"Intestinal transport and metabolism of bile acids","volume":"56","author":"Dawson","year":"2015","journal-title":"J. Lipid. Res."},{"key":"10.1016\/j.jlr.2025.100910_bib2","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.2741\/3399","article-title":"The enterohepatic circulation of bile acids in mammals: form and functions","volume":"14","author":"Hofmann","year":"2009","journal-title":"Front. Biosci."},{"key":"10.1016\/j.jlr.2025.100910_bib3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1055\/s-2000-9426","article-title":"Hepatic transport of bile salts","volume":"20","author":"Kullak-Ublick","year":"2000","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.jlr.2025.100910_bib4","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00424-006-0152-8","article-title":"The bile salt export pump","volume":"453","author":"Stieger","year":"2007","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.jlr.2025.100910_bib5","series-title":"Physiology of the Gastrointestinal Tract (Sixth Edition)","first-page":"931","article-title":"Chapter 41 - bile formation and the enterohepatic circulation","author":"Dawson","year":"2018"},{"key":"10.1016\/j.jlr.2025.100910_bib6","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1172\/JCI117722","article-title":"Cloning and molecular characterization of the ontogeny of a rat ileal sodium-dependent bile acid transporter","volume":"95","author":"Shneider","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jlr.2025.100910_bib7","doi-asserted-by":"crossref","first-page":"6960","DOI":"10.1074\/jbc.M412752200","article-title":"The heteromeric organic solute transporter alpha-beta, Ostalpha-Ostbeta, is an ileal basolateral bile acid transporter","volume":"280","author":"Dawson","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jlr.2025.100910_bib8","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/0016-5085(94)90821-4","article-title":"In situ localization of the hepatocytic Na+\/Taurocholate cotransporting polypeptide in rat liver","volume":"107","author":"Stieger","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jlr.2025.100910_bib9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jhep.2012.08.002","article-title":"Bile acid transporters and regulatory nuclear receptors in the liver and beyond","volume":"58","author":"Halilbasic","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jlr.2025.100910_bib10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/B978-0-12-394316-3.00004-1","article-title":"The SLC10 carrier family: transport functions and molecular structure","volume":"70","author":"D\u00f6ring","year":"2012","journal-title":"Curr. Top Membr."},{"key":"10.1016\/j.jlr.2025.100910_bib11","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1172\/JCI119355","article-title":"Primary bile acid malabsorption caused by mutations in the ileal sodium-dependent bile acid transporter gene (SLC10A2)","volume":"99","author":"Oelkers","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jlr.2025.100910_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113154","article-title":"Targeting bile acid signaling for the treatment of liver diseases: from bench to bed","volume":"152","author":"Duan","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jlr.2025.100910_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110835","article-title":"ASBT(SLC10A2): a promising target for treatment of diseases and drug discovery","volume":"132","author":"Yang","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jlr.2025.100910_bib14","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2174\/092986706776361003","article-title":"Bile acid reabsorption inhibitors (BARI): novel hypolipidemic drugs","volume":"13","author":"Kramer","year":"2006","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jlr.2025.100910_bib15","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.atherosclerosis.2003.08.019","article-title":"SC-435, an ileal apical sodium co-dependent bile acid transporter (ASBT) inhibitor lowers plasma cholesterol and reduces atherosclerosis in Guinea pigs","volume":"171","author":"West","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2025.100910_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/CS20230934","article-title":"Bile salt signaling and bile salt-based therapies in cardiometabolic disease","volume":"138","author":"Groenen","year":"2024","journal-title":"Clin. Sci. (Lond)."},{"key":"10.1016\/j.jlr.2025.100910_bib17","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/HEP.0000000000000376","article-title":"A3907, a systemic ASBT inhibitor, improves cholestasis in mice by multiorgan activity and shows translational relevance to humans","volume":"78","author":"Caballero-Camino","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jlr.2025.100910_bib18","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jhep.2023.10.035","article-title":"Inhibition of the renal apical sodium dependent bile acid transporter prevents cholemic nephropathy in mice with obstructive cholestasis","volume":"80","author":"Ghallab","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jlr.2025.100910_bib19","article-title":"Systemic ASBT inactivation protects against liver damage in obstructive cholestasis in mice","volume":"4","author":"Kunst","year":"2022","journal-title":"JHEP Rep."},{"key":"10.1016\/j.jlr.2025.100910_bib20","doi-asserted-by":"crossref","first-page":"19728","DOI":"10.1074\/jbc.M702663200","article-title":"Cloning and functional characterization of human sodium-dependent organic anion transporter (SLC10A6)","volume":"282","author":"Geyer","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jlr.2025.100910_bib21","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1007\/s00204-014-1379-3","article-title":"Transport of the soy isoflavone daidzein and its conjugative metabolites by the carriers SOAT, NTCP, OAT4, and OATP2B1","volume":"89","author":"Grosser","year":"2015","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.jlr.2025.100910_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.689757","article-title":"Substrate specificities and inhibition pattern of the solute carrier family 10 members NTCP, ASBT and SOAT","volume":"8","author":"Grosser","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.jlr.2025.100910_bib23","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ejmech.2015.01.011","article-title":"Interaction of human organic anion transporter polypeptides 1B1 and 1B3 with antineoplastic compounds","volume":"92","author":"Marada","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jlr.2025.100910_bib24","doi-asserted-by":"crossref","first-page":"G66","DOI":"10.1152\/ajpgi.00263.2020","article-title":"Long-term trans-inhibition of the hepatitis B and D virus receptor NTCP by taurolithocholic acid","volume":"320","author":"Lowjaga","year":"2021","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.jlr.2025.100910_bib25","doi-asserted-by":"crossref","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","article-title":"PubChem substance and compound databases","volume":"44","author":"Kim","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jlr.2025.100910_bib26","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41422-022-00680-4","article-title":"Structure of human NTCP reveals the basis of recognition and sodium-driven transport of bile salts into the liver","volume":"32","author":"Liu","year":"2022","journal-title":"Cell Res."},{"key":"10.1016\/j.jlr.2025.100910_bib27","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/s41586-022-04845-4","article-title":"Structure of the bile acid transporter and HBV receptor NTCP","volume":"606","author":"Asami","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jlr.2025.100910_bib28","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jlr.2025.100910_bib29","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1093\/bioinformatics\/btu426","article-title":"YASARA View - molecular graphics for all devices - from smartphones to workstations","volume":"30","author":"Krieger","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jlr.2025.100910_bib30","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1038\/s41467-024-46706-w","article-title":"Structure of antiviral drug bulevirtide bound to hepatitis B and D virus receptor protein NTCP","volume":"15","author":"Liu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jlr.2025.100910_bib31","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1016\/S0022-2275(20)32090-3","article-title":"Substrate specificity of the ileal and the hepatic Na(+)\/bile acid cotransporters of the rabbit. II. A reliable 3D QSAR pharmacophore model for the ileal Na(+)\/bile acid cotransporter","volume":"40","author":"Baringhaus","year":"1999","journal-title":"J. Lipid. Res."},{"key":"10.1016\/j.jlr.2025.100910_bib32","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jlr.2025.100910_bib33","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jlr.2025.100910_bib34","article-title":"Pervasive role of pruritus in impaired quality of life in patients with primary biliary cholangitis: data from the GLIMMER study","volume":"9","author":"Smith","year":"2025","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.jlr.2025.100910_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-78618-2","article-title":"Selective hepatitis B and D virus entry inhibitors from the group of pentacyclic lupane-type betulin-derived triterpenoids","volume":"10","author":"Kirstgen","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jlr.2025.100910_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108268","article-title":"Hepatic solute carrier transporters and drug therapy: regulation of expression and impact of genetic variation","volume":"238","author":"Nies","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jlr.2025.100910_bib37","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/nature10450","article-title":"Crystal structure of a bacterial homologue of the bile acid sodium symporter ASBT","volume":"478","author":"Hu","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jlr.2025.100910_bib38","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nature12811","article-title":"Structural basis of the alternating-access mechanism in a bile acid transporter","volume":"505","author":"Zhou","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jlr.2025.100910_bib39","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3390\/biomedicines10010196","article-title":"Multitasking Na(+)\/Taurocholate cotransporting polypeptide (NTCP) as a drug target for HBV infection: from protein engineering to drug discovery","volume":"10","author":"Zakrzewicz","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.jlr.2025.100910_bib40","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/s41586-022-04723-z","article-title":"Structural basis of sodium-dependent bile salt uptake into the liver","volume":"606","author":"Goutam","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jlr.2025.100910_bib41","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/s41586-022-04857-0","article-title":"Structural insights into the HBV receptor and bile acid transporter NTCP","volume":"606","author":"Park","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jlr.2025.100910_bib42","doi-asserted-by":"crossref","first-page":"14916","DOI":"10.1021\/bi0205404","article-title":"Identification of a region of the ileal-type sodium\/bile acid cotransporter interacting with a competitive bile acid transport inhibitor","volume":"41","author":"Hallen","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.jlr.2025.100910_bib43","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.mce.2016.03.028","article-title":"Identification of novel inhibitors of the steroid sulfate carrier 'sodium-dependent organic anion transporter' SOAT (SLC10A6) by pharmacophore modelling","volume":"428","author":"Grosser","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jlr.2025.100910_bib44","doi-asserted-by":"crossref","first-page":"19342","DOI":"10.1021\/acs.jmedchem.4c01743","article-title":"Structure-activity relationships and target selectivity of phenylsulfonylamino-benzanilide inhibitors based on S1647 at the SLC10 carriers ASBT, NTCP, and SOAT","volume":"67","author":"Wannowius","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jlr.2025.100910_bib45","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jsbmb.2017.09.013","article-title":"Transport of steroid 3-sulfates and steroid 17-sulfates by the sodium-dependent organic anion transporter SOAT (SLC10A6)","volume":"179","author":"Grosser","year":"2018","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jlr.2025.100910_bib46","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3389\/fphar.2018.00941","article-title":"Estrone-3-Sulfate stimulates the proliferation of T47D breast cancer cells stably transfected with the sodium-dependent organic anion transporter SOAT (SLC10A6)","volume":"9","author":"Karakus","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jlr.2025.100910_bib47","doi-asserted-by":"crossref","first-page":"9926","DOI":"10.3390\/ijms24129926","article-title":"Role of the sodium-dependent organic anion transporter (SOAT\/SLC10A6) in physiology and pathophysiology","volume":"24","author":"Wannowius","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jlr.2025.100910_bib48","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"eLife"},{"key":"10.1016\/j.jlr.2025.100910_bib49","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1128\/JVI.01902-09","article-title":"Fine mapping of pre-S sequence requirements for hepatitis B virus large envelope protein-mediated receptor interaction","volume":"84","author":"Schulze","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.jlr.2025.100910_bib50","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1007\/s00018-018-2892-y","article-title":"The functional role of sodium taurocholate cotransporting polypeptide NTCP in the life cycle of hepatitis B, C and D viruses","volume":"75","author":"Eller","year":"2018","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.jlr.2025.100910_bib51","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1515\/hsz-2022-0345","article-title":"Interactions of Na(+)\/taurocholate cotransporting polypeptide with host cellular proteins upon hepatitis B and D virus infection: novel potential targets for antiviral therapy","volume":"404","author":"Zakrzewicz","year":"2023","journal-title":"Biol. Chem."},{"key":"10.1016\/j.jlr.2025.100910_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115956","article-title":"Role of sodium taurocholate cotransporting polypeptide (NTCP) in HBV-induced hepatitis: opportunities for developing novel therapeutics","volume":"219","author":"Zhang","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jlr.2025.100910_bib53","doi-asserted-by":"crossref","first-page":"5973","DOI":"10.1021\/acs.jmedchem.1c00078","article-title":"Design of dimeric bile acid derivatives as potent and selective human NTCP inhibitors","volume":"64","author":"Liu","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jlr.2025.100910_bib54","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/hep.31712","article-title":"Dual agonist of farnesoid X receptor and takeda G protein-coupled receptor 5 inhibits hepatitis B virus infection in vitro and in vivo","volume":"74","author":"Ito","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jlr.2025.100910_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/v13081489","article-title":"Identification of novel HBV\/HDV entry inhibitors by pharmacophore- and QSAR-guided virtual screening","volume":"13","author":"Kirstgen","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.jlr.2025.100910_bib56","doi-asserted-by":"crossref","first-page":"11945","DOI":"10.1128\/JVI.01855-15","article-title":"Specifically inhibits the entry of hepatitis B and D viruses by targeting sodium taurocholate cotransporting polypeptide","volume":"89","author":"Kaneko","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.jlr.2025.100910_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/v14040764","article-title":"Fungal secondary metabolite exophillic acid selectively inhibits the entry of hepatitis B and D viruses","volume":"14","author":"Kobayashi","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.jlr.2025.100910_bib58","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.antiviral.2014.03.017","article-title":"Use of FDA approved therapeutics with hNTCP metabolic inhibitory properties to impair the HDV lifecycle","volume":"106","author":"Blanchet","year":"2014","journal-title":"Antiviral. Res."},{"key":"10.1016\/j.jlr.2025.100910_bib59","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jhep.2014.05.018","article-title":"Kinetics of the bile acid transporter and hepatitis B virus receptor Na+\/taurocholate cotransporting polypeptide (NTCP) in hepatocytes","volume":"61","author":"K\u00f6nig","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jlr.2025.100910_bib60","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jhep.2013.11.022","article-title":"Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor","volume":"60","author":"Nkongolo","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jlr.2025.100910_bib61","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15338-0","article-title":"Reduced hepatitis B and D viral entry using clinically applied drugs as novel inhibitors of the bile acid transporter NTCP","volume":"7","author":"Donkers","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jlr.2025.100910_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/v13040666","article-title":"Hepatitis D virus entry inhibitors based on repurposing intestinal bile acid reabsorption inhibitors","volume":"13","author":"Kirstgen","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.jlr.2025.100910_bib63","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00424-003-1168-y","article-title":"Organic anion transporting polypeptides of the OATP\/SLC21 family: phylogenetic classification as OATP\/SLCO superfamily, new nomenclature and molecular\/functional properties","volume":"447","author":"Hagenbuch","year":"2004","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.jlr.2025.100910_bib64","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jlr.2025.100910_bib65","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1124\/dmd.121.000595","article-title":"Pharmacokinetics and ADME characterization of intravenous and oral [(14)C]-Linerixibat in healthy male volunteers","volume":"49","author":"Zamek-Gliszczynski","year":"2021","journal-title":"Drug Metab. Dis."},{"key":"10.1016\/j.jlr.2025.100910_bib66","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.1021\/jm400459m","article-title":"Discovery of a highly potent, nonabsorbable apical sodium-dependent bile acid transporter inhibitor (GSK2330672) for treatment of type 2 diabetes","volume":"56","author":"Wu","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jlr.2025.100910_bib67","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00424-013-1367-0","article-title":"Sodium-dependent bile salt transporters of the SLC10A transporter family: more than solute transporters","volume":"466","author":"Anwer","year":"2014","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.jlr.2025.100910_bib68","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.mam.2012.07.004","article-title":"The solute carrier family 10 (SLC10): beyond bile acid transport","volume":"34","author":"Claro da Silva","year":"2013","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.jlr.2025.100910_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2020.166764","article-title":"Dissecting the conformational dynamics of the bile acid transporter homologue ASBT(NM)","volume":"433","author":"Lu","year":"2021","journal-title":"J. Mol. Biol."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227525001725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227525001725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T08:55:05Z","timestamp":1764147305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227525001725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":69,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0022227525001725"],"URL":"https:\/\/doi.org\/10.1016\/j.jlr.2025.100910","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carrier cross-reactivities of the bile acid reabsorption inhibitors elobixibat, linerixibat, maralixibat, and odevixibat","name":"articletitle","label":"Article Title"},{"value":"Journal of Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jlr.2025.100910","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology\u00e9","name":"copyright","label":"Copyright"}],"article-number":"100910"}}